Building IP: Patent Grant re "Regulation of gene expression using engineered nucleases" | SGMO Message Board Posts

Sangamo Therapeutics, Inc.

  SGMO website

  •  Registered Members of Investor Village:
    Please make sure you are signed in to your Investor Village account to enjoy the full benefits of our service and avoid the MediaPass paywall. If the MediaPass offer page is blocking you, click the light blue "No thanks, take me back" link on the middle right side of the form to get to our home page where you can sign in by entering your Investor Village User Name and Password. 

     MediaPass subscribers: Please make sure you are logged in to your MediaPass subscription to bypass the paywall. You can do this by clicking the light blue "Already have a MediaPass account? Login here" link on the middle left side of the subscription offer form and then entering the email address and password you used when you first signed up with MediaPass.  

    For assistance call 888-222-7309 or email admin@investorvillage.com

SGMO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  141806 of 147742  at  2/18/2020 10:33:43 AM  by

spaddy


 In response to msg 141804 by  JBWIN
view thread

Re: Building IP: Patent Grant re "Regulation of gene expression using engineered nucleases"

 " By way of non-limiting example, a wild type gene, e.g. encoding at least one globin (e.g., a globin, .gamma. globin, .beta. globin and combinations thereof), may be inserted into a cell (e.g., into an endogenous BCL11A enhancer sequence using one or more nucleases as described herein) to provide the globin proteins deficient or lacking in the cell and thereby treat a genetic disease, e.g., a hemoglobinopathy, caused by faulty globin expression."
 
Interesting that they are considering inserting the normal beta globulin gene or fetal gene at the site of the BCL11A enhancer knockout.
 
This would not only knock out the BCLA11 enhancer but would also produce the beta/fetal hemoglobin also..
2 birds, one stone.
 
They probably aren't just inserting the new healthy gene at the normal beta globin site for some reason..no one else is doing that either..
Possibly gene is too large to completely cut out and then insert entire new gene?
Problems with knocking out endogenous beta globin gene with the deleted area causing problems with cell development?
Anyway, no one else doing it either, so there must be an issue.
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 9     Views: 328
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...